Fig. 2From: Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosisMedium chain acylcarnitines and the C4/C8 ratio of MCADD patients versus controls; *ā=āsignificant difference pĀ <ā0.05Back to article page